Anti-obesity drugs: to be or not to be?

Research output: Contribution to journalEditorialResearchpeer-review

Standard

Anti-obesity drugs : to be or not to be? / Dvorak, R.V.; Sharma, A.M.; Astrup, Arne.

In: Obesity Reviews, Vol. 11, No. 12, 2010, p. 833-834.

Research output: Contribution to journalEditorialResearchpeer-review

Harvard

Dvorak, RV, Sharma, AM & Astrup, A 2010, 'Anti-obesity drugs: to be or not to be?', Obesity Reviews, vol. 11, no. 12, pp. 833-834. https://doi.org/10.1111/j.1467-789X.2010.00828.x

APA

Dvorak, R. V., Sharma, A. M., & Astrup, A. (2010). Anti-obesity drugs: to be or not to be? Obesity Reviews, 11(12), 833-834. https://doi.org/10.1111/j.1467-789X.2010.00828.x

Vancouver

Dvorak RV, Sharma AM, Astrup A. Anti-obesity drugs: to be or not to be? Obesity Reviews. 2010;11(12):833-834. https://doi.org/10.1111/j.1467-789X.2010.00828.x

Author

Dvorak, R.V. ; Sharma, A.M. ; Astrup, Arne. / Anti-obesity drugs : to be or not to be?. In: Obesity Reviews. 2010 ; Vol. 11, No. 12. pp. 833-834.

Bibtex

@article{3509d3f0f25611dfb6d2000ea68e967b,
title = "Anti-obesity drugs: to be or not to be?",
author = "R.V. Dvorak and A.M. Sharma and Arne Astrup",
year = "2010",
doi = "10.1111/j.1467-789X.2010.00828.x",
language = "English",
volume = "11",
pages = "833--834",
journal = "Obesity Reviews",
issn = "1467-7881",
publisher = "Wiley-Blackwell",
number = "12",

}

RIS

TY - JOUR

T1 - Anti-obesity drugs

T2 - to be or not to be?

AU - Dvorak, R.V.

AU - Sharma, A.M.

AU - Astrup, Arne

PY - 2010

Y1 - 2010

U2 - 10.1111/j.1467-789X.2010.00828.x

DO - 10.1111/j.1467-789X.2010.00828.x

M3 - Editorial

C2 - 21054758

VL - 11

SP - 833

EP - 834

JO - Obesity Reviews

JF - Obesity Reviews

SN - 1467-7881

IS - 12

ER -

ID: 23208347